The FIB-4 index combines age, two liver enzymes, and platelet count into a single non-invasive score that estimates the probability of advanced liver fibrosis. It is widely used in hepatitis C and NAFLD care to decide who can skip a biopsy and who needs further testing.
How FIB-4 works
FIB-4 is calculated as (Age × AST) ÷ (Platelets × √ALT). Sterling RK and colleagues first described it in 2006 as a simple, low-cost alternative to liver biopsy for staging fibrosis in patients with HIV/HCV coinfection, and it was later validated more broadly in chronic hepatitis C and nonalcoholic fatty liver disease (NAFLD).
The formula rewards a combination that reflects advancing fibrosis: rising liver enzymes, a falling platelet count (a marker of portal hypertension), and older age. Because it only requires values already on a routine blood panel, FIB-4 can be calculated at essentially no additional cost.
Inputs and units
Age is entered in years. AST and ALT are entered in U/L, as reported on a standard liver panel or comprehensive metabolic panel. Platelet count is entered in ×10⁹/L — the same numeric value as the ×10³/µL unit used on most complete blood count (CBC) reports, so no conversion is required.
All four values should come from the same blood draw whenever possible, since mixing labs from different dates can produce a misleading score.
Why age matters — and the limits of FIB-4
Because age sits directly in the numerator, FIB-4 rises with age even when true fibrosis has not progressed, which inflates false-positive rates in older adults. To correct for this, guidance derived from McPherson et al. (2017) uses an age-adjusted low-risk cutoff of below 2.00 for patients 65 and older, instead of the standard 1.30 cutoff used under 65. The high-risk cutoff of above 2.67 is unchanged across age groups.
FIB-4 was validated primarily in HCV, HIV/HCV coinfection, and NAFLD populations — it is not intended for acute liver injury, and an indeterminate or high score should prompt confirmatory testing (transient elastography or biopsy) rather than a standalone diagnosis.